A website map of the section for people with COPD is shown in figure 1. The section aims at supporting self-management skills including activities such as physical activity, physical training, ...

The diagnostic criteria for CIDP that were developed by the EFNS/PNS1 are most commonly used and distinguish CIDP from other neuropathic conditions with high sensitivity and specificity. Nevertheless, ...

As a result, the specificity of IBP was lower and the diagnostic gain of IBP was smaller than expected. In the rheumatology setting no striking differences among defined IBP criteria (Calin, Berlin, ...

The results of this review of response to treatment forms part of the diagnostic ... oxygen rather than the criteria for deciding who needs oxygen therapy. Exacerbations are now recognised as key ...

Background In hospitalised patients with exacerbation of Chronic Obstructive Pulmonary ... history of 10 or more cigarette pack years. Exclusion criteria were any illness, other than COPD, that was ...

University of Alabama at Birmingham-led researchers have refined and validated a new framework for diagnosing chronic ...

Objective: COPD is one of the major causes of morbidity and mortality worldwide. Health care providers should counsel their smoking patients with COPD to quit smoking as the first treatment step.

This study evaluated the potential impact of starting LTOT on acute exacerbation and hospital burden in patients with chronic obstructive pulmonary disease (COPD), interstitial ... and not fulfilling ...

Current recommendations for diagnosis of COPD in patients with respiratory symptoms require detection of airflow obstruction ...

Incorporating chest CT imaging and respiratory symptoms into the chronic obstructive pulmonary disease (COPD) diagnostic ...

These guidelines on oesophageal manometry and gastro-oesophageal reflux monitoring supersede those produced in 2006. Since 2006 there have been significant technological advances, in particular, the ...

Current diagnostic criteria for PLS may be a barrier to therapeutic development, requiring long delays between symptom onset and formal diagnosis. While new technologies sensitive to both upper and ...